New study tests if albumin changes can forecast sepsis survival better than current methods.
NCT ID NCT07289906
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares two blood tests—mass change in serum albumin and serum lactic acid—to see which better predicts whether non-surgical ICU patients with sepsis will be discharged or die. Researchers will track 40 adults aged 18-70 with sepsis, excluding those with liver disease or certain kidney conditions. The goal is to find a more reliable way to forecast sepsis prognosis.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could give doctors a more accurate tool to predict whether sepsis patients will recover or worsen, helping guide treatment decisions.
What could go wrong
This is a small, early-stage study with only 40 participants, so results may not apply to all patients. The test is not a treatment and will not directly improve outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospitals ofAin shams university
Cairo, Elabasya, Egypt